Skip to content

Use of Blood Product to deliver drugs in treatment of gum diseases

Injectable liquid Platelet Rich Fibrin (iPRF) as a vehicle for local drug delivery (LDD) in periodontal therapy - A Randomised Controlled clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048659
Enrollment
75
Registered
2023-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Group 1 - Drug Loaded iPRF(Injectable Platelet Rich Fibrin ): After Scaling and Root Planing (SRP), this group will be treated with Doxycycline loaded iPRF for localised periodontal poc

Sponsors

Thamaraiselvan Murugan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient selection was done according to the 2017 World Work­ shop on the Classification of Periodontal and Peri­Implant Diseases and Conditions. Patients with Stage II Grade B peri­odontitis (moderate periodontitis) were included. Patients having a minimum of 2 sites with probing depth (PD) > 5 mm and clinical attachment loss (CAL) >4 mm with horizontal bone loss at 2 different quadrants, and requiring non­surgical treat­ment were considered as eligible for the study.

Exclusion criteria

Exclusion criteria: Patients with habits, like smoking, tobacco chewing or alcohol consumption, having uncontrolled diabetes, hyper­ tension or immunocompromised conditions, pregnant women or lactating mothers, non­compliant or physically challenged people, and those who were not able to main­ tain oral hygiene or be followed up at a recall visit

Design outcomes

Primary

MeasureTime frame
Probing Depth (PD), Clinical Attachment Level (CAL), Gingival Index (GI), plaque Index (PI),Timepoint: Baseline (BL), 6th week, 12th week

Secondary

MeasureTime frame
Salivary Glutathione levels, Salivary collagenase levels, p.gingivalis levelsTimepoint: Baseline (BL), 6th week, 12th week

Countries

India

Contacts

Public ContactThamaraiselvan Murugan

Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences

Thamaraiselvanperiodontics@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026